Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention

X Yin, X Yin, X Pan, J Zhang, X Fan, J Li… - Frontiers in …, 2023 - frontiersin.org
Cardiac fibrosis plays an indispensable role in cardiac tissue homeostasis and repair after
myocardial infarction (MI). The cardiac fibroblast-to-myofibroblast differentiation and …

Epicardium-Derived Tbx18+ CDCs Transplantation Improve Heart Function in Infarcted Mice

Z Guo, M Geng, L Qin, B Hao, S Liao - Frontiers in Cardiovascular …, 2022 - frontiersin.org
Cardiosphere-derived cells (CDCs) constitute a cardiac stem cell pool, a promising
therapeutics in treating myocardial infarction (MI). However, the cell source of CDCs remains …

The epicardial delivery of cardiosphere derived cells or their extracellular vesicles is safe but of limited value in experimental infarction

V Crisóstomo, C Baéz-Diaz, V Blanco-Blázquez… - Scientific Reports, 2021 - nature.com
The epicardial administration of therapeutics via the pericardial sac offers an attractive route,
since it is minimally invasive and carries no risks of coronary embolization. The aim of this …

Efecto de las células madre cardiacas sobre el sustrato arrítmico epicárdico en un modelo de posinfarto

A Carta Bergaz - 2023 - docta.ucm.es
Efecto de las células madre cardiacas sobre el sustrato arrítmico epicárdico en un modelo de
posinfarto Page 1 UNIVERSIDAD COMPLUTENSE DE MADRID FACULTAD DE MEDICINA …

Isolation, culture and, characterization of Cardiosphere-Derived Cells (CDCs)

V Álvarez, JG Casado, R Blázquez, F Marinaro… - 2022 - researchsquare.com
Abstract Cardiosphere-derived Cells (CDCs) can be isolated from cardiac tissues of pigs.
The protocol begins with an enzymatic digestion followed by a pre-culture in a specific cell …

[PDF][PDF] Epicardial Delivery of Cardiosphere Derived Cells or Their Extracellular Vesicles in a Relevant Infarcted Swine Model: Safe, Easy but of Limited Effectiveness.

V Crisostomo, C Baez-Diaz, V Blanco-Blazquez… - 2021 - scholar.archive.org
The epicardial administration of therapeutics via the pericardial sac offers an attractive route,
since it is minimally invasive and carries no risks of coronary embolization. The aim of this …